About the Journal

Biomedical Research and Theory Letters (BRTL) is an international peer‑reviewed journal dedicated to advancing the frontiers of biomedical science through the integration of theory, experimentation, and clinical application. The journal provides a platform for disseminating high‑quality research that bridges fundamental discoveries in the laboratory with translational and clinical practices, while also encouraging theoretical contributions that enrich the conceptual foundations of biomedical knowledge. By fostering dialogue between empirical research and theoretical frameworks, BRTL seeks to promote innovation, methodological rigor, and interdisciplinary collaboration across the biomedical sciences.

The scope of BRTL encompasses a wide range of disciplines, including molecular biology, biochemistry, genetics, physiology, microbiology, and biomedical engineering. The journal also welcomes submissions in clinical medicine, covering areas such as pathology, pharmacology, immunology, oncology, neurology, cardiology, and infectious diseases. Translational research is a central focus, particularly studies on biomarkers, personalized medicine, and novel therapeutic strategies that connect laboratory findings to patient care. In addition, BRTL recognizes the growing importance of bioinformatics, systems biology, and computational modeling, and invites contributions that employ data‑driven approaches to elucidate complex biomedical phenomena. Public health, epidemiology, and evidence‑based health policy are also within the journal’s scope, ensuring that research published in BRTL has both scientific and societal impact.

Focus

  • To publish cutting‑edge biomedical research that integrates theory, experimentation, and clinical application.

  • To foster multidisciplinary approaches connecting fundamental biomedical sciences and medical practice.

  • To provide space for theoretical and methodological contributions that strengthen the conceptual framework of biomedical science.

  • To promote translational research bridging laboratory discoveries with clinical practice and public health policy.

  • To serve as a reference for researchers, clinicians, academics, and policymakers seeking authoritative insights into biomedical advances.

  • To uphold scientific integrity, open data practices, and international publication ethics.

Scope

BRTL accepts original research articles, systematic reviews, meta‑analyses, case reports, short communications, and theoretical papers covering the following areas:

  • Fundamental Biomedical Sciences

    • Molecular biology, biochemistry, genetics, physiology, microbiology.

    • Studies on disease mechanisms, biomarkers, and innovative therapies.

  • Medical and Clinical Sciences

    • Pathology, pharmacology, immunology, oncology, neurology, cardiology, infectious diseases.

    • Prospective and retrospective clinical studies, controlled trials, and case reports.

  • Medical Microbiology

    • Host–microbe interactions, bacterial and viral pathogenesis.

    • Diagnostic microbiology, antimicrobial resistance, and development of therapeutic strategies.

  • Public Health and Translational Research

    • Epidemiology, environmental health, and evidence‑based health policy.

    • Translational studies linking laboratory findings to clinical and societal applications.

  • Theoretical and Conceptual Studies

    • Biomedical theoretical models.

    • Philosophical, methodological, and ethical discussions in biomedical research.

  • Parasitology

    • Studies on parasites and host–parasite interactions.

    • Research on parasitic diseases, diagnostics, prevention, and therapeutic strategies.

  • Pharmacy

    • Pharmaceutical sciences, drug discovery, formulation, and pharmacokinetics.

    • Clinical pharmacy, pharmacovigilance, and rational drug use.

  • Nursing Science

    • Nursing practice, patient care models, and clinical decision‑making.

    • Research on nursing education, community health nursing, and evidence‑based nursing interventions.

  • Interdisciplinary and Emerging Fields

    • Bioethics, biostatistics, and precision medicine.

    • Artificial intelligence in biomedicine, digital health, and telemedicine.